3–4 Sept 2026
ALBA Synchrotron
Europe/Madrid timezone

Multi-Scale AI-Based Segmentation and Characterisation of Hepatic Microvasculature in Porto-Sinusoidal Vascular Disease Using Synchrotron X-ray Phase-Contrast Imaging

3 Sept 2026, 17:40
1h 20m
Experimental hall (ALBA Synchrotron)

Experimental hall

ALBA Synchrotron

Speaker

Emily Ji Lam

Description

Porto-Sinusoidal Vascular Disease (PSVD) is a life-threatening chronic liver disorder, primarily driven by severe portal hypertension complications [1]. Currently, definitive clinical diagnosis relies on the identification of specific and non-specific non-cirrhotic histological microvascular lesions, such as the progressive obliteration of intrahepatic portal venules (OPV) and portal vein stenosis, detectable through Light Microscopy (LM) [2]. Yet, the precise cellular and structural mechanisms underlying this disease remain poorly characterised, leaving a critical gap in both understanding and clinical management [3]. Addressing this gap requires mapping the liver’s highly specialised hierarchical vascular architecture. While being useful for lesion detection, conventional 2D LM fails capture this 3D organization: it requires tissue slicing and staining, which may introduce artifacts and only offers 2D perspectives of a continuous 3D vascular architecture [4]. Synchrotron X-ray Phase-Contrast Imaging (X-PCI) overcomes these limitations by enabling non-destructive 3D visualisation of intact biopsies with high soft tissue contrast and sub-micron resolution (0.65 μm) [5]. Nevertheless, imaging the full multi-scale vascular architecture generates massive terabyte-scale datasets that overload computational memory when processed entirely at maximum resolution, demanding specialised processing strategies.

To address this computational challenge, we developed an efficient multiscale AI-based pipeline (Figure 1 in attachments) applied to liver biopsies from control and PSVD rat models [6] imaged at the FaXToR beamline (ALBA Synchrotron) [7]. First, we performed bit depth reduction and standardised the reconstructed measurements through contrast normalization. Next, we stitched the samples using an in-house adaptation of different resolutions levels: Binning 4 (2.6 µm), 2 (1.3 µm) and 1 (native, 0.65 µm). We utilised the resulting stitching parameters to map the global macrovascular tree. Resolution-specific nnU-Net models [8] then segmented the vascular architecture at each scale: a binary model mapped large vessel walls at low resolution (DSC = 0.988), while a multiclass model delineated terminal sinusoids and suppressed background at higher resolutions, producing a continuous vascular representation from macrovessels to sinusoids.

As a preliminary result, a resolution-dependent logical subtraction isolated the exclusive microvascular component, revealing a severe 28.33% density reduction in the diseased sample. This capillary dropout is completely hidden under downsampled regimes, proving that native maximum resolution is mandatory to detect microvascular pruning. Furthermore, a spatial translation framework integrated the 3D surface meshes from multiple resolutions into a single coordinate system, enabling the simultaneous visualisation shown in Figure 1 (in attachments). Together, these results establish a non-destructive multiscale pipeline for characterising the structural remodelling underlying PSVD, with potential applicability to other vascular anatomies including placental, pulmonary and coronary networks.

References:
[1] A. De Gottardi, C. Sempoux, and A. Berzigotti, “Porto-sinusoidal vascular disorder,” Journal of Hepatology, vol. 77, no. 4, pp. 1124–1135, Oct. 2022, doi: 10.1016/j.jhep.2022.05.033.
[2] A. De Gottardi et al., “Porto-sinusoidal vascular disease: proposal and description of a novel entity,” The Lancet Gastroenterology & Hepatology, vol. 4, no. 5, pp. 399–411, May 2019, doi: 10.1016/S2468-1253(19)30047-0.
[3] G. Campreciós, B. Bartrolí, C. Montironi, E. Belmonte, J. C. García-Pagán, and V. Hernández-Gea, “Porto-sinusoidal vascular disorder,” in Sinusoidal Cells in Liver Diseases, Elsevier, 2024, pp. 445–464. doi: 10.1016/B978-0-323-95262-0.00022-X.
[4] R. Xuan et al., “Phase-contrast computed tomography: A correlation study between portal pressure and three dimensional microvasculature of ex vivo liver samples from carbon tetrachloride-induced liver fibrosis in rats,” Microvascular Research, vol. 125, p. 103884, Sep. 2019, doi: 10.1016/j.mvr.2019.103884.
[5] A. Patera et al., “FaXToR: the hard X-ray micro-tomography beamline at the Spanish synchrotron ALBA,” J Synchrotron Rad, vol. 33, no. 1, pp. 207–217, Jan. 2026, doi: 10.1107/S160057752500997X.
[6] G. Campreciós et al., “Interspecies transcriptomic comparison identifies a potential PORTO‐SINUSOIDAL vascular disorder rat model suitable for in vivo drug testing,” Liver International, vol. 44, no. 1, pp. 180–190, Jan. 2024, doi: 10.1111/liv.15765.
[7] A. Patera, A. G. Zippo, A. Bonnin, M. Stampanoni, and G. E. M. Biella, “Brain micro‐vasculature imaging: An unsupervised deep learning algorithm for segmenting mouse brain volume probed by high‐resolution phase‐contrast X‐ray tomography,” Int J Imaging Syst Tech, vol. 31, no. 3, pp. 1211–1220, Sep. 2021, doi: 10.1002/ima.22520.
[8] H. Goharbavang, A. T. Ashitkov, A. Pillai, J. D. Wythe, G. Chen, and D. Mayerich, “Segmentation and modeling of large-scale microvascular networks: a survey,” Front. Bioinform., vol. 5, p. 1645520, Oct. 2025, doi: 10.3389/fbinf.2025.1645520.

Authors

Alessandra Patera Prof. Bart Bijnens (Universitat Pompeu Fabra, Barcelona, Spain. ICREA, Barcelona, Spain.) Emily Ji Lam Dr Gabriel Bernardino (Universitat Pompeu Fabra, Barcelona, Spain) Dr Genís Campreciós (Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, FRCB-IDIBAPS (Fundació de Recerca Clínic Barcelona – Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE-Liver). Centro de Referencia del Sistema Nacional de Salud en Enfermedad Hepática Compleja (CSUR), Barcelona, Catalonia, Spain.) Prof. Joan Carles Garcia Pagan (Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, FRCB-IDIBAPS (Fundació de Recerca Clínic Barcelona – Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE-Liver). Centro de Referencia del Sistema Nacional de Salud en Enfermedad Hepática Compleja (CSUR), Barcelona, Catalonia, Spain.) Mariana Lourenço Seabra (University Pompeu Fabra)

Presentation materials

There are no materials yet.